SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
暂无分享,去创建一个
T. Honda | U. Tateishi | Kota Yokoyama | Y. Miyazaki | Y. Ishikawa | S. Kirimura | Tsubasa Okazaki | Jyunichi Tsuchiya
[1] C. Cyran,et al. PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions , 2020, European Radiology Experimental.
[2] S. Ikeda,et al. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report. , 2020, Immunotherapy.
[3] B. Krause,et al. FDG PET Hybrid Imaging. , 2020, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[4] David R. Jones,et al. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] S. Sugita,et al. Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report , 2019, Thoracic cancer.
[6] A. Cesne,et al. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] M. Tsuboi,et al. Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report , 2019, Thoracic cancer.
[8] J. Blay,et al. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses , 2019, The American journal of surgical pathology.
[9] X. Buy,et al. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients , 2019, European Radiology.
[10] Publisher's Note , 2018, Anaesthesia.
[11] T. Kohno,et al. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities , 2017, Modern Pathology.
[12] N. Girard,et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas , 2015, Nature Genetics.